Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)

CAPS Rating: 2 out of 5

Recs

1
Player Avatar BuffettJunior1 (97.64) Submitted: 10/16/2011 7:16:05 PM : Underperform Start Price: $3.02 NAVB Score: +117.20

Extremely overvalued trash stock.

Featured Broker Partners


Advertisement